Prospective Study
Copyright ©The Author(s) 2021.
World J Orthop. Jun 18, 2021; 12(6): 423-432
Published online Jun 18, 2021. doi: 10.5312/wjo.v12.i6.423
Table 1 Details of the baseline and platelet rich plasma platelets and white cells concentrations

Initial platelet concentration
PRP
%
Platelets, median (IQR)264500 (247000-278000)1125500 (1088000-1340500)444 (407-519)
WC, median (IQR)5200 (4790-6480)600 (220-810)10 (3-15)
Table 2 Demographic data

Group 1, n = 21
Group 2, n = 19
P value
Age in yr, median (IQR)25 (22-39)31 (26-34)0.54
Male, n (%)15 (71.4)19 (100)0.02
FU in mo, median (IQR)25 (18-36)25 (18-30)0.86
MRI tear location:
Proximal, n (%)10 (48)12 (63)
Mid-substance, n (%)11 (52)7 (27)
Table 3 Results at final follow-up
Baseline
Group 1, n = 21
Group 2, n = 19
P value
Lysholm score, median (IQR)69.5 (43.0-85.0)54.0 (41.0-77.0)0.41
IKDC score, median (IQR)58.5 (44.0-60.0)58.0 (44.0-60.0)0.84
TAL, mean ± SD6.90 ± 1.076.70 ± 1.180.65
At final follow-up
Lysholm score, median (IQR)80 (75-90)80 (73-86)0.53
IKDC score, median (IQR)77 (71-89)71 (70-79)0.33
TAL, mean ± SD6.70 ± 1.526.50 ± 1.610.7
RTS rate, n (%)20 (95)18 (95)0.9
Time to RTS in mo, mean ± SD3.8 ± 0.84.3 ± 1.20.09
Failure rate, n (%)7 (33)6 (31)0.9
Table 4 Magnetic resonance image Van Meer classification at baseline and at 6 mo
MRI Van Meer classification

Group 1
Group 2
P value
Baseline MRI, mean ± SD6.1 ± 1.76.2 ± 2.40.97
MRI at 6 mo follow-up, mean ± SD3.4 ± 2.93.6 ± 2.50.82